Publication | Closed Access

Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma

HepatologyViral HepatitisLiver PhysiologyMedicineImmunologySerum MicrornasCirrhosisPathologyHepatitisNovel Non-invasive BiomarkersHcv-positive CirrhosisLiver DiseaseLiver CancerMicrorna DetectionMolecular DiagnosticsTumor MicroenvironmentHepatocellular CarcinomaCancer Research